Telix Pharmaceuticals Limited (ASX:TLX)

Telix Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,808	8,238	3,263	2,300	2,209	1,060
Market Cap Growth	-54.53%	152.44%	41.89%	4.10%	108.44%	169.99%
Enterprise Value	4,130	8,141	3,145	2,180	2,161	1,039
Last Close Price	11.24	24.61	10.08	7.27	7.75	3.78
PE Ratio	172.82	165.02	626.21	-	-	-
Forward PE	434.38	87.27	32.83	-	-	-
PS Ratio	3.76	10.52	6.49	14.37	290.85	203.33
PB Ratio	5.92	14.50	21.91	28.75	1023.78	13.41
P/TBV Ratio	-	54.17	83.14	109.40	-	53.46
P/FCF Ratio	259.05	286.95	229.72	-	-	619.12
P/OCF Ratio	110.33	191.44	136.63	-	-	540.78
EV/Sales Ratio	4.08	10.39	6.26	13.62	284.54	199.24
EV/EBITDA Ratio	67.46	92.95	55.00	-	-	-
EV/EBIT Ratio	96.36	99.41	60.60	-	-	-
EV/FCF Ratio	280.96	283.58	221.37	-	-	606.68
Debt / Equity Ratio	0.99	1.02	0.12	0.13	1.18	0.03
Debt / EBITDA Ratio	10.42	6.47	0.30	-	-	-
Debt / FCF Ratio	43.40	20.26	1.23	-	-	1.29
Asset Turnover	0.79	0.82	1.52	0.88	0.06	0.04
Inventory Turnover	10.97	10.79	15.36	10.92	1.25	3.45
Quick Ratio	1.11	2.60	1.18	1.90	1.13	4.62
Current Ratio	1.33	2.78	1.41	2.03	1.25	4.69
Return on Equity (ROE)	3.14%	13.92%	4.55%	-253.34%	-198.36%	-60.21%
Return on Assets (ROA)	2.08%	5.33%	9.81%	-25.37%	-37.95%	-23.64%
Return on Capital (ROIC)	3.12%	7.78%	25.26%	-97.35%	-118.20%	-40.13%
Return on Capital Employed (ROCE)	3.20%	6.90%	21.50%	-43.60%	-113.10%	-35.70%
Earnings Yield	0.43%	0.61%	0.16%	-4.53%	-3.64%	-4.23%
FCF Yield	0.39%	0.35%	0.43%	-3.09%	-2.75%	0.16%
Buyback Yield / Dilution	37.99%	-6.64%	-4.21%	-10.08%	-9.69%	-10.21%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.